REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Asher Pharma S A S (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Asher Pharma S A S Profile Updated: April 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Asher Pharma S A S is based in Colombia, with the head office in Bogota D.C.. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was established on September 27, 2013. The total number of employees is currently 3 (2025). From the latest financial highlights, Asher Pharma S A S reported a net sales revenue drop of 5.96% in 2024. Its total assets decreased by 7% over the same period.

Headquarters
Carrera 16 A 78 79
Bogota D.C.; Bogota D.C; Postal Code: 0812

Contact Details: Purchase the Asher Pharma S A S report to view the information.

Basic Information
Total Employees:
Purchase the Asher Pharma S A S report to view the information.
Financial Auditors:
Purchase the Asher Pharma S A S report to view the information.
Incorporation Date:
September 27, 2013
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Company Performance
Financial values in the chart are available after Asher Pharma S A S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-5.96%▼
Total operating revenue
-5.96%▼
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
N/A
Total assets
-7%▼
Total equity
1.38%▲
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
0.4%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo